Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival

Míreanna comhchosúla

• Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival
  de réir: Ezgi Ozyerli-Goknar, et al.
  Foilsithe / Cruthaithe: (2023-11-01)
• EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities
  de réir: Yedier-Bayram, O, et al.
  Foilsithe / Cruthaithe: (2022)
• The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma
  de réir: Ozyerli-Goknar, E, et al.
  Foilsithe / Cruthaithe: (2019)
• Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
  de réir: Saraç, H, et al.
  Foilsithe / Cruthaithe: (2019)
• Homeotic shift at the dawn of the turtle evolution
  de réir: Tomasz Szczygielski
  Foilsithe / Cruthaithe: (2017-01-01)